Celularity (CELU) Intangibles (2020 - 2025)
Celularity's (CELU) quarterly Intangibles came in at $24.0 million in Q4 2025, little changed year-over-year from $24.0 million in Q4 2024, and little changed quarter-over-quarter from $24.0 million in Q3 2025.
Analysis
Celularity (CELU) Intangibles (2020 - 2025) Analysis & Trends
Celularity (CELU) has reported Intangibles for 6 consecutive years, with $24.0 million the latest figure, recorded in Q4 2025.
- On a quarterly basis, Intangibles changed 0.0% year-over-year to $24.0 million in Q4 2025; TTM through Dec 2025 was $24.0 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $24.0 million, changed 0.0% from the prior year.
- Intangibles was $24.0 million for Q4 2025 at Celularity, roughly flat from $24.0 million in the prior quarter.
- Over five years, Intangibles peaked at $123.7 million in Q3 2021 and troughed at $9.6 million in Q3 2024.
- A 5-year average of $58.5 million and a median of $24.0 million in 2023 frame the typical range for Intangibles.
- Across the five-year window, Intangibles slumped 91.32% in 2024 and surged 149.3% in 2025, its largest moves.
- Over 5 years, Intangibles stood at $123.2 million in 2021, then retreated by 1.78% to $121.0 million in 2022, then sank by 80.17% to $24.0 million in 2023, then changed by 0.0% to $24.0 million in 2024, then changed by 0.0% to $24.0 million in 2025.
- The last three Intangibles figures came in at $24.0 million (Q4 2025), $24.0 million (Q3 2025), and $24.0 million (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn | 330.24 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 62.10 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn | 2.55 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | 30.61 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 5.31 Mn |
| 10 | Celularity | 36.35 Mn | 30.17 Mn | -3.27 Mn | 23.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 23.99 Mn |
| Sep 30, 2025 | 23.99 Mn |
| Jun 30, 2025 | 23.99 Mn |
| Mar 31, 2025 | 23.99 Mn |
| Dec 31, 2024 | 23.99 Mn |
| Sep 30, 2024 | 9.62 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Mar 31, 2024 | 10.46 Mn |
| Dec 31, 2023 | 23.99 Mn |
| Sep 30, 2023 | 11.55 Mn |
| Jun 30, 2023 | 12.11 Mn |
| Mar 31, 2023 | 120.45 Mn |
| Dec 31, 2022 | 120.99 Mn |
| Sep 30, 2022 | 121.55 Mn |
| Jun 30, 2022 | 122.10 Mn |
| Mar 31, 2022 | 122.65 Mn |
| Dec 31, 2021 | 123.19 Mn |
| Sep 30, 2021 | 123.74 Mn |
| Dec 31, 2020 | 125.38 Mn |